Medical AI Alliance
← Company Index
Pharma & CDMOKOSPI 001060606 approvals65 trials

JW PHARMACEUTICAL

Official website

Founded in 1945, JW Pharmaceutical holds an original drug pipeline including Rivalo and Hemlibra, plus the IV nutrition product Winuf and OTC brand Hwakol.

As of 2026-10-10, JW PHARMACEUTICAL has 292 Korean MFDS device approvals, 314 Korean MFDS drug approvals, 22 PubMed-indexed papers on record (counted by the MAA Company Index from its own matching of public databases).

Price

Change

Market cap

Business overview

Source: DART corporate disclosure

Founded in 1945 and listed on KOSPI in 1976, JW Pharmaceutical is a pharmaceutical company. It holds an original drug pipeline including Rivalo, Hemlibra, Trupass, Sigmart, and Actemra, plus the third-generation three-chamber nutritional IV fluid Winuf, combining omega-3 and omega-6, and it obtained approval for a combination new drug pairing pitavastatin with ezetimibe. In its 70th fiscal year, separate-entity revenue rose 8.0% (about KRW 56.6 billion) year-on-year to KRW 767.2 billion and operating profit rose 18.1% (about KRW 14.8 billion) to KRW 96.6 billion, and in August 2019 the company acquired 100% of Vietnam's Euvipharm.

Products & technology

  • Rivalo
  • Hemlibra
  • Trupass
  • Sigmart
  • Actemra
  • WinufThird-generation three-chamber nutritional IV fluid combining omega-3 and omega-6
  • HwakolComprehensive cold medicine (OTC)
  • HimomWound-type care band (OTC)
  • Friends EyedropArtificial tears (OTC)
  • Pitavastatin-Ezetimibe combination drugCombination new drug for circulatory/endocrine indications

Regulatory approvals

data.go.kr

314 Korean MFDS drug approvals · 1955–2026 / 292 Korean MFDS device approvals · 1977–2026

  • MFDS drugGANETATHIONE Tab.2026-08-21
    Drug · OTC · Notification202602422
  • MFDS drugJPCAB Tablet 10mg(Vonoprazan Fumarate)2026-07-08
    Drug · Prescription · Approval202601988
  • MFDS drugJPCAB Tablet 20mg(Vonoprazan Fumarate)2026-07-08
    Drug · Prescription · Approval202601989
  • MFDSDiagnostic spirometer2026-06-04
    Product approval · Class 2수인 26-4383 호
  • MFDS drugEmpa-guard100/12.5mg2026-05-11
    Drug · Prescription · Approval202601360
  • MFDS drugEmpa-guard100/5mg2026-05-11
    Drug · Prescription · Approval202601361
  • MFDS drugThruenza Soft Capsule 40mg2026-04-30
    Drug · Prescription · Approval202601305
  • MFDS drugFacol C Cough S Soft Cap.2026-04-21
    Drug · OTC · Notification202601162
  • MFDS drugLivaloZet Tablet 1/10mg2026-03-12
    Drug · Prescription · Approval202600749
  • MFDS drugFacol Nose Tab.2026-02-03
    Drug · OTC · Notification202600303
  • MFDS drugJritol Tab.2026-01-22
    Drug · Prescription · Approval202600199
  • MFDS drugLIVALO HI Tab 2/160/10mg2025-09-30
    Drug · Prescription · Approval202502593
Show 68 more
  • MFDS drugLIVALO HI Tab 2/160/5mg2025-09-30
    Drug · Prescription · Approval202502594
  • MFDSDiagnostic spirometer2025-09-26
    Product approval · Class 2수인 25-4567 호
  • MFDS drugLIVALO HI Tab 4/160/10mg2025-09-24
    Drug · Prescription · Approval202502532
  • MFDS drugLIVALO HI Tab 2/80/5mg2025-09-24
    Drug · Prescription · Approval202502533
  • MFDS drugLIVALO HI Tab 4/160/5mg2025-09-24
    Drug · Prescription · Approval202502534
  • MFDS drugLIVALO HI Tab 4/80/5mg2025-09-24
    Drug · Prescription · Approval202502535
  • MFDSLight system, surgical2025-08-11
    Product approval · Class 1수신 25-1743 호
  • MFDSLight system, surgical2025-07-22
    Product approval · Class 1수신 25-1575 호
  • MFDS drugLivaloFeno Cap.2025-05-29
    Drug · Prescription · Approval202501340
  • MFDS drugJCLE Tab.2025-05-27
    Drug · Prescription · Approval202501316
  • MFDSLight system, surgical2025-05-16
    Product approval · Class 1수신 25-977 호
  • MFDSCamera, still, surgical2025-05-15
    Product approval · Class 1수신 25-966 호
  • MFDS drugJW ibuprofen premix2025-04-07
    Drug · Prescription · Approval202500806
  • MFDS drugASBERIN capsule 100/5mg2025-03-27
    Drug · Prescription · Approval202500715
  • MFDS drugTavalisse Tab. 150mg2025-01-20
    Drug · Prescription · Approval202500147
  • MFDS drugTavalisse Tab. 100mg2025-01-20
    Drug · Prescription · Approval202500148
  • MFDS drugFacol Tab.2024-11-21
    Drug · OTC · Notification202402751
  • MFDSTable, operation, electrically-powered2024-11-08
    Product approval · Class 1수신 24-2120 호
  • MFDSPatient positioning or immobilization device2024-10-29
    Product approval · Class 1수신 24-2032 호
  • MFDS drugFrenz Eye One Cool Eye Drops(Carboxymethylcellulose sodium)(single use)2024-09-19
    Drug · OTC · Notification202402254
  • MFDS drugRABEKHAN DUO Tab. 20/700mg2024-08-30
    Drug · Prescription · Approval202402099
  • MFDS drugRABEKHAN DUO Tab. 10/700mg2024-08-30
    Drug · Prescription · Approval202402100
  • MFDS drugFrenz Eyedrop Ice2024-04-11
    Drug · OTC · Notification202400824
  • MFDS drugMobilia Inj.(Plerixafor)2023-11-21
    Drug · Prescription · Approval202303176
  • MFDS drugJardimet Tab. 12.5/850mg2023-09-04
    Drug · Prescription · Approval202302630
  • MFDS drugJardimet Tab. 12.5/1000mg2023-09-04
    Drug · Prescription · Approval202302631
  • MFDS drugJardimet Tab. 12.5/500mg2023-09-04
    Drug · Prescription · Approval202302632
  • MFDS drugAlgyquick Soft Cap.2023-08-22
    Drug · OTC · Notification202302483
  • MFDSIncubator, infant2022-12-05
    Product approval · Class 3제허 22-821 호
  • MFDSIncubator, infant2022-11-24
    Product approval · Class 3제허 22-795 호
  • MFDSIncubator, infant2022-11-22
    Product approval · Class 3제허 22-786 호
  • MFDS drugENAROY tablet 1mg(Enarodustat)2022-11-17
    Drug · Prescription · Approval202204160
  • MFDS drugENAROY tablet 2mg(Enarodustat)2022-11-17
    Drug · Prescription · Approval202204161
  • MFDS drugENAROY tablet 4mg(Enarodustat)2022-11-17
    Drug · Prescription · Approval202204162
  • MFDSX-ray system, diagnostic, general-purpose, digitalRevoked2022-09-29
    Product approval · Class 2제인 22-4730 호
  • MFDSX-ray system, diagnostic, general-purpose, digitalRevoked2022-09-29
    Product approval · Class 2제인 22-4729 호
  • MFDSIncubator, infant2022-08-23
    Product approval · Class 3제허 22-572 호
  • MFDSIncubator, infant2022-08-23
    Product approval · Class 3제허 22-571 호
  • MFDSIncubator, infant2022-08-23
    Product approval · Class 3제허 22-568 호
  • MFDS drugJW Donepezil Sol2022-07-18
    Drug · Prescription · Approval202202999
  • MFDSPatient positioning or immobilization deviceRevoked2022-05-09
    Product approval · Class 1수신 22-800 호
  • MFDS drugJardimet Tab. 5/850mg2022-04-29
    Drug · Prescription · Approval202201741
  • MFDS drugJardimet Tab. 5/500mg2022-04-29
    Drug · Prescription · Approval202201742
  • MFDS drugJardimet Tab. 5/1000mg2022-04-29
    Drug · Prescription · Approval202201743
  • MFDS drugFrenz eyedrop care(single use)2022-03-24
    Drug · OTC · Notification202201175
  • MFDS drugSUBRION Injection(sugammadex sodium)2022-02-11
    Drug · Prescription · Approval202200671
  • MFDSPatient positioning or immobilization deviceRevoked2021-12-28
    Product approval · Class 1수신 21-2355 호
  • MFDS drugLivaloZet Tablet 2/10mg2021-07-28
    Drug · Prescription · Approval202105578
  • MFDS drugLivaloZet Tablet 4/10mg2021-07-28
    Drug · Prescription · Approval202105579
  • MFDSTable, examination/treatment, gynaecological, electrically- poweredRevoked2021-06-30
    Product approval · Class 1수신 21-1213 호
  • MFDSLight, examination, mobile2021-06-11
    Product approval · Class 1수신 21-1078 호
  • MFDSLight, examination, mobile2021-05-26
    Product approval · Class 1수신 21-943 호
  • MFDSLight system, surgical2021-04-30
    Product approval · Class 1제신 21-594 호
  • MFDSLight system, surgical2021-04-09
    Product approval · Class 1수신 21-595 호
  • MFDSTable, operation, electrically-powered2021-03-30
    Product approval · Class 1수신 21-528 호
  • MFDSLight, examination2021-03-23
    Product approval · Class 1수신 21-469 호
  • MFDSCamera, still, surgical2021-03-17
    Product approval · Class 1수신 21-440 호
  • MFDS drugJardiheart Tab. 25mg(Empagliflozin)2021-03-12
    Drug · Prescription · Approval202102269
  • MFDS drugJardiheart Tab. 10mg(Empagliflozin)2021-03-12
    Drug · Prescription · Approval202102270
  • MFDS drugGANETOC Solution2021-03-05
    Drug · OTC · Notification202102087
  • MFDSDiagnostic spirometer2021-03-04
    Product approval · Class 2수인 21-4089 호
  • MFDS drugRABEGRONRevoked2021-02-18
    Drug · Prescription · Approval202101474
  • MFDSTable, examination/treatment, general-purpose, electrohydraulicRevoked2020-12-11
    Product approval · Class 1제신 20-1836 호
  • MFDS drugMydrop eye drop (polydeoxyribonucleotide sodium)(single use)2020-11-23
    Drug · OTC · Notification202008115
  • MFDS drugMOENDEX Tab. 100mgRevoked2020-11-18
    Drug · OTC · Notification202007966
  • MFDS drugJRELTO Tab. 15mgRevoked2020-09-04
    Drug · Prescription · Approval202006171
  • MFDS drugJRELTO Tab. 10mgRevoked2020-09-04
    Drug · Prescription · Approval202006172
  • MFDS drugNopen felbinac cataplasma2020-08-19
    Drug · OTC · Notification202005892

Showing the 80 most recent of 606 records.

Clinical trials

data.go.kr

65 MFDS clinical trial authorisations · 2012–2026 (Phase 1 37 · Bioequivalence 14 · Phase 3 9 · Phase 2a 3 · Phase 2b 1)

  • Phase 1JW01132026-10-02

    2 trial sites

  • Phase 1JW01122026-07-02

    2 trial sites

  • Phase 1JW01122026-07-02

    2 trial sites

  • Phase 1JW01112026-04-30

    2 trial sites

  • Phase 1JW0901 C25022026-03-19

    2 trial sites

  • Phase 1JW00612026-02-12

    1 trial site

  • Phase 1URC102정2025-12-08

    1 trial site

  • Phase 3KLH-21092025-09-22

    55 trial sites

  • Phase 1JW0104, C24092025-06-11

    2 trial sites

  • Phase 1JW0104, C2409, C24102025-06-11

    2 trial sites

  • BioequivalenceJW06022025-01-13

    2 trial sites

  • Phase 3JW0108, C24072025-01-06

    14 trial sites

Show 53 more
  • Phase 1JW01052024-10-07

    1 trial site

  • Phase 3JW0104, C24022024-08-30

    20 trial sites

  • Phase 1URC102정2024-07-30

    1 trial site

  • Phase 1JW01072024-06-26

    1 trial site

  • Phase 1JW22862024-06-18

    1 trial site

  • Phase 1JW02042024-04-17

    1 trial site

  • Phase 1URC102정2024-02-19

    1 trial site

  • Phase 1JW02022023-08-02

    2 trial sites

  • Phase 1JW0104, C22072023-06-27

    2 trial sites

  • Phase 1JW02032023-03-23

    1 trial site

  • Phase 1JW01022023-02-10

    2 trial sites

  • Phase 1JW03022023-01-10

    1 trial site

  • Phase 3URC102정2022-11-24

    29 trial sites

  • Phase 3JW02012022-09-28

    34 trial sites

  • Phase 3JW02012022-09-28

    20 trial sites

  • Phase 1JW03012022-05-13

    1 trial site

  • Phase 1URC102정2021-11-12

    2 trial sites

  • Phase 1JW02012021-11-11

    1 trial site

  • Phase 3JW0101/C21012021-08-09

    21 trial sites

  • Phase 1리바로VA정4/160/10밀리그램2021-05-04

    1 trial site

  • Bioequivalence에소메칸정40밀리그램(에스오메프라졸마그네슘삼수화물)2021-04-27

    2 trial sites

  • Bioequivalence제이더블유중외제약도네페질정10밀리그램(도네페질염산염수화물)2020-11-12

    2 trial sites

  • Phase 1리바로정4밀리그램(피타바스타틴칼슘), 디오반필름코팅정160밀리그램(발사르탄), 노바스크정10밀리그램(암로디핀베실산염)2020-08-28

    1 trial site

  • Bioequivalence리바로정1밀리그램(피나바스타틴칼슘)2019-09-03

    2 trial sites

  • Bioequivalence리바로정2밀리그램(피타바스타틴칼슘)2019-08-09

    2 trial sites

  • Phase 3JW0108, C24072019-06-11

    25 trial sites

  • Phase 2bURC102정2018-11-15

    10 trial sites

  • Phase 1JW16012018-11-06

    2 trial sites

  • Phase 1리바로E정4/10mg(가칭)2018-10-19

    1 trial site

  • Phase 4가드렛정 100mg2018-10-19

    27 trial sites

  • Phase 3JTZ-9512018-08-07

    28 trial sites

  • Phase 1리바로E정4/10mg(가칭)2018-08-06

    1 trial site

  • Bioequivalence올멕포스에이치정 5/20/12.5 밀리그램2017-09-01

    2 trial sites

  • Bioequivalence제이다트정0.5밀리그램(두타스테리드)2017-04-05

    2 trial sites

  • Bioequivalence올멕포스에이치정 10/40/12.5밀리그램2017-02-13

    2 trial sites

  • Phase 2aCWP232291(가칭)2016-12-14

    3 trial sites

  • Phase 1테노펙션정2016-02-01

    1 trial site

  • Phase 2aURC102정2015-07-31

    4 trial sites

  • Phase 1URC102정2015-06-29

    1 trial site

  • Bioequivalence페북사트정(페북소스타트)2015-03-09

    2 trial sites

  • Phase 1CWP232291(가칭)2015-02-25

    3 trial sites

  • Phase 1가드렛복합정100/1000mg(가칭)2014-12-09

    1 trial site

  • Bioequivalence트루패스디정8밀리그램(실로도신)2014-07-11

    2 trial sites

  • Phase 1아나글립틴(Anagliptin)2014-06-02

    1 trial site

  • Phase 2aURC102정2014-04-07

    5 trial sites

  • Phase 1리바로복합정4/160mg(가칭)2014-02-27

    1 trial site

  • Bioequivalence제이더블유중외제약주식회사 제이카정(가칭)(Amlodipine besylate 13.888 mg / Olmesartan medoxomil 40 mg)2014-01-14

    2 trial sites

  • Bioequivalence리바로정2밀리그램(피타바스타틴칼슘)2013-05-28

    2 trial sites

  • Phase 1URC102정2013-05-02

    1 trial site

  • Phase 1리바로정, 디오반필름코팅정2012-12-10

    1 trial site

  • Bioequivalence중외로잘탄정(로자탄칼륨)2012-09-05
  • Bioequivalence발사포스정10/160밀리그램2012-06-29

    1 trial site

  • Phase 1CWP232291(가칭)2012-02-15

    3 trial sites

Global clinical trials

ClinicalTrials.gov · sponsor-matched
Show 67 more trials

R&D and key agreements

Source: DART corporate disclosure

C&C신약연구소 · Joint-venture new drug research institute established with Chugai Pharmaceutical of Japan in 1992

JW Theriac · Chemogenomics research institute established in Seattle, US in 2001

Key disclosures

KRX KIND via OpenDART

Publications

PubMed · affiliation-matched
Show 12 more publications

Patents

KIPRIS · applicant-matched
Show 315 more patents

AI reads

MAA server logs · IP-verified
126
Times AI engines pulled JW PHARMACEUTICAL's records

Pulled records become part of each AI's index and keep feeding its answers. When an AI cites from that index, nothing reaches our server — so actual citations are uncounted here and exceed this number.

1
Fetched fresh mid-answer

Times an AI needed something not yet in its index and fetched this page fresh while answering. Citations served from the index leave no trace here.

125
Index crawls

Collected as raw material for future answers.

0
Direct AI-tool queries (MCP)

Queries from users who connected this index to their own AI.

7
live 0
Last 7 days
97
live 0
Last 30 days
126
live 1
All time
  • OpenAIChatGPT-Userlive1
  • OpenAIOAI-SearchBot102
  • GoogleGoogleOther14
  • PerplexityPerplexityBot7
  • AnthropicClaudeBot2

Measured since Aug 26, 2026 · 4 AI engines · last read Oct 8, 2026

User-agent strings can be forged, so we do not count them at face value. We count only requests matched against vendor-published IP ranges, or confirmed by forward-verified reverse DNS. MCP queries are actual calls to this index's tool endpoint.

Connect this index to your AI tool →

Connect this company index directly to your AI

Connect it to ChatGPT or Claude, and your AI queries the full record — profiles, financials, stock data, regulatory approvals, clinical trials, publications and patents — for JW PHARMACEUTICAL and every listed Korean medical, bio and AI company.

How to connect (MCP)
Not yet compiled: business overview. Send us materials and we will add them

Companies approved for the same productsPharma & CDMO

Ranked by how many MFDS product categories overlap. Not a ranking — a pointer to where to look.

SHINHUNG CO.,LTD16 shared

Founded in 1964 and KOSPI-listed in 1991, Shinhung manufactures and distributes dental equipment and materials.

DONG-A ST CO.,LTD14 shared

Dong-A ST, spun off from Dong-A Socio Holdings in 2013 and KOSPI-listed, makes prescription drugs like Growtropin, Stillen, and Bacchus.

Alpha AI Co.,Ltd.12 shared

Alpha AI, founded in 1995 and KOSDAQ-listed in 2000, manufactures biocompatible metal implants and surgical instruments.

GC Medical Science Corporation10 shared

GC Medical Science Corporation, KOSDAQ-listed since 2014, operates diagnostic reagent, blood glucose, and hemodialysis solution businesses.

Bistos Co., Ltd.8 shared

Founded in 2001 and KOSDAQ-listed in 2022, Bistos manufactures fetal, neonatal, and patient monitoring medical devices.

DENTIS CO.,LTD8 shared

Founded in 2016 and listed on KOSDAQ in 2017, DENTIS manufactures dental implants, medical LED lighting, and dental 3D printers.

ValueAddedTechnologyCo.,Ltd.6 shared

Founded in 1992 and KOSDAQ-listed in 2006, VATECH manufactures dental digital X-ray and CT imaging diagnostic devices.

SEWOONMEDICAL CO,. LTD.5 shared

Founded in 1982 and KOSDAQ-listed in 2008, Sewoon Medical manufactures medical aspirators and catheters/tubes.

HANS BIOMED CORPORATION4 shared

KOSDAQ-listed medical device company producing human tissue implants Bella Cell HD and SureFuse.

DRTECH Corporation4 shared

KOSDAQ-listed digital diagnostic imaging company providing X-ray systems, detectors, and components.

SGHEALTHCARE CO.,LTD.4 shared

Founded in 2009 and KOSDAQ-listed in 2024, SGHealthcare manufactures X-ray, CT, and MRI medical imaging diagnostic devices.

BIODYNE CO., LTD.4 shared

Founded in 1999 and KOSDAQ-listed in 2021, BIODYNE develops liquid-based cytology (LBC) devices and diagnostic reagent kits.

Sources and updates

Counts on this page are not company-reported figures. MAA matched records from DART, the Korean MFDS, the US FDA, ClinicalTrials.gov, PubMed and KIPRIS to this company itself, by business registration number or registered name, never by name similarity. They may differ from figures the company publishes.

Company basics
Korea Exchange · DART
Business content
Compiled from disclosure filings
Approvals & clinical trials
Korean MFDS (data.go.kr) · US FDA openFDA — updated weekly
Key disclosures
KRX KIND via OpenDART exchange filings — updated daily
Global clinical trials
ClinicalTrials.gov (US NIH) — sponsor-matched, updated weekly
Financials
DART corporate disclosure filings — annual
Publications
PubMed (US National Library of Medicine) — affiliation-matched, updated daily
Patents
KIPRIS (Korea Institute of Patent Information) — applicant-matched, updated monthly
AI reads
Our server logs, IP-verified every 6 hours
AI visibility
Measured 2026-10-01

This page is compiled from public sources without the company's involvement. If anything is inaccurate or incomplete, please let us know. Materials provided by the company are labelled as such.

Request a correction or addition